fda update tirzepatide Allows Compounded During Shortage Review Tirzepatide Update: On December 19th

Sergey Terushkin, MD, FACS Peptide therapy has become a common topic among patients interested in recovery, healthy aging, sleep, energy, and body composition

Side-by-side comparison v3.0 transparency score NexLife: 94/100 (6 of 6 pillars) Noom Med: 70/100 (1 of 6 pillars) Drugs offered NexLife: Compounded semaglutide + tirzepatide Noom Med: Semaglutide + Tirzepatide Pricing model NexLife: Flat $145/mo sema, $186/mo tirz (12-mo plan, dose-independent) Noom Med: $199/mo Clinical model NexLife: MD/DO-supervised, synchronous + async Noom Med: Behavioral-program-led brand telehealth Pharmacy NexLife: Named 503A & 503B partners Noom Med: Brand via partner network States covered NexLife: Availability varies by state + DC Noom Med: Varies Labs included NexLife: Yes included in monthly Noom Med: Add-on or not included Coaching NexLife: 1:1 fitness coaching + personalized nutrition included Noom Med: Varies by plan Financing NexLife: Klarna and Afterpay accepted Noom Med: Standard card payment Regulatory clarity NexLife: Pre-Rx written disclosure that compounded sema/tirz are not FDA-approved Noom Med: Varies Where Noom Med wins Tightly integrated with the Noom behavioral app ecosystem

Inspect Upon Arrival: Your peptides are shipped with care to maintain the cold chain

After 24 h, the conditioned medium (CM) was collected